Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Assets Average (2016 - 2025)

Historic Assets Average for Editas Medicine (EDIT) over the last 10 years, with Q3 2025 value amounting to $206.2 million.

  • Editas Medicine's Assets Average fell 4211.81% to $206.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $206.2 million, marking a year-over-year decrease of 4211.81%. This contributed to the annual value of $420.4 million for FY2024, which is 1704.36% down from last year.
  • Latest data reveals that Editas Medicine reported Assets Average of $206.2 million as of Q3 2025, which was down 4211.81% from $237.1 million recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Assets Average ranged from a high of $768.1 million in Q2 2021 and a low of $206.2 million during Q3 2025
  • Its 5-year average for Assets Average is $502.4 million, with a median of $503.0 million in 2023.
  • In the last 5 years, Editas Medicine's Assets Average surged by 3867.01% in 2021 and then plummeted by 4252.75% in 2025.
  • Quarter analysis of 5 years shows Editas Medicine's Assets Average stood at $697.3 million in 2021, then fell by 25.04% to $522.7 million in 2022, then dropped by 3.97% to $501.9 million in 2023, then crashed by 33.34% to $334.6 million in 2024, then crashed by 38.38% to $206.2 million in 2025.
  • Its Assets Average was $206.2 million in Q3 2025, compared to $237.1 million in Q2 2025 and $302.6 million in Q1 2025.